menu
    • menu
    [{"orgOrder":0,"company":"Hunan Mabgeek Biotechnology","sponsor":"Chime Biologics","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"CHINA","productType":"Antibody, Unconjugated","year":"2025","type":"Collaboration","leadProduct":"MG-K10","moa":"IL-4R?","graph1":"Dermatology","graph2":"Phase III","graph3":"Hunan Mabgeek Biotechnology","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Hunan Mabgeek Biotechnology \/ Hunan Mabgeek Biotechnology","highestDevelopmentStatusID":"10","companyTruncated":"Hunan Mabgeek Biotechnology \/ Hunan Mabgeek Biotechnology"},{"orgOrder":0,"company":"Hunan Mabgeek Biotechnology","sponsor":"Chime Biologics","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"CHINA","productType":"Antibody, Unconjugated","year":"2025","type":"Inapplicable","leadProduct":"MG-K10","moa":"IL-4R?","graph1":"Dermatology","graph2":"Phase III","graph3":"Hunan Mabgeek Biotechnology","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Hunan Mabgeek Biotechnology \/ Chime Biologics","highestDevelopmentStatusID":"10","companyTruncated":"Hunan Mabgeek Biotechnology \/ Chime Biologics"}]

    Find Clinical Drug Pipeline Developments & Deals by Hunan Mabgeek Biotechnology

    Menu

    Hunan Mabgeek Biotechnology

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Hunan Mabgeek Biotechnology

                            China arrow
                            AAPS
                            Not Confirmed

                            Hunan Mabgeek Biotechnology

                            China arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : MG-K10

                            Therapeutic Area : Dermatology

                            Study Phase : Phase III

                            Recipient : Chime Biologics

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10

                            Details : The collaboration aims to advancing the MG-K10, a potential Best-in-Class therapy, a novel IL-4Rα-targeting antibody drug for atopic dermatitis and asthma.

                            Product Name : Undisclosed

                            Product Type : Antibody, Unconjugated

                            Upfront Cash : Undisclosed

                            February 21, 2025

                            Lead Product(s) : MG-K10

                            Therapeutic Area : Dermatology

                            Highest Development Status : Phase III

                            Recipient : Chime Biologics

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Hunan Mabgeek Biotechnology

                            China arrow
                            AAPS
                            Not Confirmed

                            Hunan Mabgeek Biotechnology

                            China arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : MG-K10

                            Therapeutic Area : Dermatology

                            Study Phase : Phase III

                            Sponsor : Chime Biologics

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Chime, Mabgeek Hit MG-K10 PPQ Milestone for Atopic Dermatitis Drug

                            Details : MG-K10, a humanized anti-IL-4Rα monoclonal antibody, is being investigated for treating Th2-mediated inflammatory diseases such as moderate-to-severe atopic dermatitis.

                            Product Name : Undisclosed

                            Product Type : Antibody, Unconjugated

                            Upfront Cash : Inapplicable

                            January 03, 2025

                            Lead Product(s) : MG-K10

                            Therapeutic Area : Dermatology

                            Highest Development Status : Phase III

                            Sponsor : Chime Biologics

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth